Evidence map›Paper›PMID 39158538›Full record

ArticleJournal of the American Heart Association2024

Hypertension Severity as Quantified by Hypertension Daily Dose and Blood Pressure With Risk of Stroke in REGARDS.

Ying K Loo, Katherine Wilkinson, Tyler Harkness, George Howard, Virginia J Howard, Suzanne E Judd, Neil A Zakai, Paul Muntner, Lillian Min, Suzanne Oparil and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ying K LooThe Robert Larner, M.D. College of Medicine at the University of Vermont Burlington VT USA.ORCID 0000-0001-7795-5102
Katherine WilkinsonThe Robert Larner, M.D. College of Medicine at the University of Vermont Burlington VT USA.ORCID 0000-0001-6190-735X
Tyler HarknessThe Robert Larner, M.D. College of Medicine at the University of Vermont Burlington VT USA.
George HowardDepartment of Biostatistics School of Public Health University of Alabama at Birmingham Birmingham AL USA.ORCID 0000-0002-3068-5720
Virginia J HowardDepartment of Epidemiology, School of Public Health University of Alabama at Birmingham Birmingham AL USA.ORCID 0000-0003-4912-9975
Suzanne E JuddDepartment of Biostatistics School of Public Health University of Alabama at Birmingham Birmingham AL USA.ORCID 0000-0001-7594-6587
Neil A ZakaiThe Robert Larner, M.D. College of Medicine at the University of Vermont Burlington VT USA.ORCID 0000-0001-8824-4410
Paul MuntnerDepartment of Epidemiology, School of Public Health University of Alabama at Birmingham Birmingham AL USA.ORCID 0000-0002-4711-5492
Lillian MinDepartment of Medicine University of Michigan Ann Arbor VA Medical Center Geriatric Research Education Clinical Center (GRECC) Ann Arbor MI USA.ORCID 0000-0002-4149-5092
Suzanne OparilDepartment of Medicine University of Alabama at Birmingham Birmingham AL USA.ORCID 0000-0002-7505-2599
Timothy B PlanteThe Robert Larner, M.D. College of Medicine at the University of Vermont Burlington VT USA.ORCID 0000-0001-9992-9597

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is unknown how blood pressure (BP) relates to stroke risk across levels of hypertension daily dose (HDD)-quantified antihypertensive medication intensity. METHODS AND

resultsThe REGARDS (Reasons for Geographic and Racial Differences in Stroke) study enrolled 30 239 participants from the 48 contiguous US states in 2003 to 2007 with in-person follow-up in 2013 to 2016 (Visit 2). We included those without prior stroke at Visit 2, treating this visit as T

conclusionsAmong adults without prior stroke, systolic BP ≥140 mm Hg and HDD tertile ≥2 was associated with greater stroke risk. For adults with BP <140 mm Hg, stroke risk was similar despite cumulative dose of antihypertensive medications used. These findings support the practice of BP-lowering medications to mitigate stroke risk.

Indexed as

Antihypertensive AgentsBlood PressureHypertensionStrokeAgedFemaleHumansIncidenceMaleMiddle AgedRisk AssessmentRisk FactorsSeverity of Illness IndexTime FactorsUnited StatesAntihypertensive Agentsantihypertensive medicationsblood pressurecohort studyhypertensionstroke

Identifiers

PMID39158538
PMCPMC11646496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.